Abstract
The type I intermediate filament keratin 16 (K16) is constitutively expressed in ectoderm-derived appendages and is inducibly expressed in the epidermis upon barrier-compromising challenges. Dominantly acting missense alleles in KRT16 are causative for pachyonychia congenita (PC), a genodermatosis involving debilitating palmoplantar keratoderma (PPK), nail dystrophy, oral lesions and, frequently, alterations in glands and hair. C57Bl/6;Krt16−/− mice develop oral lesions early after birth and PC-like PPK lesions as young adults. These PPK lesions have a marked dysregulation of skin barrier-related genes and innate immunity effectors (eg danger-associated molecular patterns) and are preceded by oxidative stress secondary to hypoactive Nrf2 signalling. These molecular features are present in PPK lesions of PC patients. Here, we report that all components of the C57Bl/6;Krt16−/− mouse phenotype occur as well in the FVB strain background, albeit less severely so, a significant observation in the light of variations in the clinical presentation of individuals harbouring disease-causing mutations in the KRT16 gene.
Keywords: keratin, keratinocyte, keratoderma, mouse model, skin
1 | INTRODUCTION
Keratin 16 (K16), a type I intermediate filament gene and protein, is constitutively expressed in specific cell types in ectoderm-derived epithelial appendages (eg hair follicles, nail, glands, oral papillae etc.) and is inducibly expressed when stratified epithelia such as the epidermis are experiencing stress (eg UV exposure, wounding) or disease (eg psoriasis, carcinoma).[1] Genetic linkage analyses and DNA sequencing determined that dominantly acting missense alleles in KRT16 are causative for pachyonychia congenita (PC),[2] a genodermatosis involving painful and debilitating palmoplantar keratoderma (PPK), nail dystrophy, oral lesions and, frequently, alterations in glands and hair as well.[3] Focal non-epidermolytic PPK lesions, which occur at pressure points in palms and soles, involve dramatic epidermal thickening and hyperkeratosis and are often significantly painful for patients. Of note, similar alleles in KRT16 can elicit a presentation of focal non-epidermolytic PPK in the absence of other lesions characteristic of PC,[4] suggesting that the consequences associated with alterations in KRT16 are subject to modifier gene(s) effects.
Mice null for Krt16, originally generated in the C57Bl/6 background, develop oral lesions early after birth and PC-like PPK lesions as young adults.[5] Follow-up studies showed that the lesions in footpad skin involve a gross misregulation of skin barrier-related genes, including danger-associated molecular patterns(DAMPs; also known as alarmins) and effectors of innate immunity[6] and are preceded and caused by a state of oxidative stress secondary to misregulation of Keap1-Nrf2 signalling.[7] Several of the key features of PPK-like lesions in footpad skin of C57Bl/6;Krt16−/− mice are present in PPK lesions of individuals with PC.[6,7] Here, we describe the phenotype associated with the Krt16 null allele in the FVB mouse strain background. This study was conducted for the primary purpose of defining the role of Krt16 in HPV16-induced carcinogenesis in the FVB background (see Ref.[8]) but provided an opportunity to assess the impact of genetic strain background on expression of the Krt16−/− phenotype.
2 | RESULTS AND DISCUSSION
The Krt16 null allele was transferred to the FVB strain background via six sequential backcrosses of C57Bl/6;Krt16+/− and wild-type FVB mice. Intercrosses between FVB;Krt16+/− were next conducted and the progeny analysed. A third of FVB;Krt16−/− offspring dies within a day after birth, while ~50% of these mice survive to adulthood (Figure 1A), which is slightly more than what had been observed in the C57Bl/6 strain (by 17%;[5]). Macroscopic examination at postnatal day 5 (P5) reveals whitish and raised plaques (oral leukoplakia) in the posterior aspect of the dorsal tongue epithelium FVB;Krt16−/− mice, but not in FVB;Krt16+/− or FVB;Krt16+/+ mice (Figure 1B). Histologically, examination of sagittal cross sections of this area of the dorsal tongue reveals a mildly thickened, disorganized and occasionally cytolytic epithelium (Figure 1C), with a normal complement of oral papilla (data not shown), at P5. Immunostaining of similar tissue sections reveals that expression of the differentiation-related K13 (Figure 1D) and its partner K4 (data not shown) is unaltered, whereas that of K17 is dramatically reduced in the dorsal tongue epithelium of FVB;Krt16−/− mice (Figure 1E). Altogether these observations, summarized in Figure S1, show that the survival at weaning and the character of oral lesions in FVB;Krt16−/− mice are similar to, but not as severe, as those previously reported for C57Bl/6;Krt16−/− mice.5
FIGURE 1.

FVB;Krt16−/− mice have increased mortality compared to WT and develop oral lesions. (A) Survival curve of FVB;Krt16 mice. n = 31-36 mice/genotype. ** denotes P < .01 determined by log-rank test. (B) Pictures of macroscopic tongue plaques that occur in FVB;Krt16−/− mice (both sexes) at P5. (C) H&E staining of P5 tongues to evaluate histology of female FVB;Krt16−/− tongue lesions. Scale bar, 50 μm (D and E) immunostaining for K13 and K17 in sections of fresh frozen tongue tissue from P5 male littermates
At the 2 months mark postbirth, surviving FVB;Krt16−/− mice still weigh less compared to WT littermates (Table S1). All surviving male and female FVB;Krt16−/− mice develop PPK-like lesions on their front paws (Figure 2A), as we reported for C57Bl/6;Krt16−/− mice.[5] Male mice exhibit a slightly earlier onset of PPK relative to females (average 4.67 ± 0.37 vs 5.04 ± 0.41 weeks; see Figure 2D) and also exhibit a greater PPK index, a macroscopic and blinded measure of lesion severity, at 6 weeks of age (Figure 2, A, E). A similar sex bias for PPK onset also occurs in C57Bl/6;Krt16−/− mice.[9] Histologically, the paw skin of FVB;Krt16−/− mice exhibits thickened epidermis and modest hyperkeratosis starting at 4 weeks (Figure 2B) and peaking at 8 weeks (Figure 2C; sex-specific quantitation reported in Figure 2F). Lesional footpad skin shows decreased staining for filaggrin (Figure 2H), suggesting impaired epidermal differentiation, a ~2.5-fold increase in phosphorylated Histone H3-positive nuclei in the basal layer of FVB;Krt16−/− relative to FVB;Krt16+/+ epidermis, indicating a mild state of hyperproliferation (Figure 2G), and cells positive for the innate immune cell marker CD11b, suggesting an inflammatory infiltrate (Figure 2I). These observations are qualitatively similar to those made when characterizing C57Bl/6;Krt16−/− mice5 (see Figure S1).
FIGURE 2.

FVB;Krt16−/− mice develop PPK lesions. (A) Images of 6-week-old male (left) and female (right) FVB;Krt16−/− mice displaying macroscopic appearance of PPK lesions compared to controls. (B and C) H&E staining of front paw skin sections relating histological changes in 4- and 8-week-old FVB;Krt16−/− male mice. Dotted line corresponds to dermal/epidermal junction. Epi, epidermis; SC, stratum corneum. Scale bar, 50 μm. (D) Quantitation of PPK lesion onset in both sexes of FVB;Krt16−/− mice. Mice were scored as lesional when evidence of macroscopic lesions (waxy keratoderma) was present. n = 4-5 mice/sex. (E) Quantitation of PPK lesions severity based on presence of waxy keratoderma on front paws of 6-week-old FVB;Krt16 mice. n = 2-4 mice/sex/genotype. (F) Sex-specific quantitation of epidermal thickness from 8-week-old FVB;Krt16 front paws. n = 2-3 mice/genotype. (G) Quantitation of proliferation (measured by P-Histone H3 staining) in front paw skin from 8-week-old male FVB;Krt16 mice. n = 3 mice/genotype. (H) Immunostaining for filaggrin (green) and keratin 5 (red) in front paw skin from 8-week-old male FVB;Krt16 mice. (I) Immunostaining for CD11b (green) and p65 (red) in front paw skin from 8-week-old male FVB;Krt16 mice. Scale bar, 50 μm. (J) Transcript levels for danger-associated molecular patterns (DAMPs) in front paw skin from 8-week-old FVB;Krt16 null mice relative to WT controls. *denotes P < .05, and ** denotes P < .01 as determined by unpaired 2-tailed Student’s t test on dCq values
Next, we assessed some of the key molecular readouts that had been shown to be misregulated in footpad skin of C57Bl/6;Krt16−/− mice. Emphasis was placed on mRNA levels for DAMPs (danger-associated molecular patterns; see[6]), key effectors of the glutathione-based antioxidant system and of the Keap1-Nrf2 system.[7] Transcript levels for Krt6a, the type II partner gene for Krt16 and a sensitive indicator of cell and tissue stress, and of several DAMPS including DefB4, S100A8 and S100A9 were markedly elevated (Figure 2J). Additionally, the mRNA transcript levels for Sprr2d and SerpinB3a, which contribute to genesis of the cornified envelope, were also markedly elevated (Figure 2J). Some of these findings were corroborated at the protein level, for example, by Western blotting for S100A8 and the activated form of IL-1β (data not shown). These observations suggest that while qualitatively similar, the alterations occurring in the skin barrier are less severe in FVB;Krt16−/− relative to C57Bl/6;Krt16−/− mice.
One of the key justifications of this set of experiments was to assess the impact of Krt16 loss for HPV16tg/+-induced tumorigenesis in FVB mouse skin (see[8]). FVB;Krt16+/− mice were thus bred to the FVB;HPVtg/+ mouse line as described.[8] Remarkably, 100% of the Krt16−/−;HPVtg/+ mice died within 2 weeks after birth (Table S2). While the cause of death remains undefined and calls for substantive follow-up studies, the outcome of this cross is indicative of a strong genetic interaction between the HPV16 transgene and the Krt16 null allele.
In conclusion, our findings suggest that while genetic strain background does not impact the presentation of the Krt16 null phenotype in mouse at a qualitative level, it does influence the intensity of virtually all aspects of the presentation, ranging from perinatal lethality to the severity of oral and PPK lesions. Differences in inflammatory responses between C57Bl/6 and FVB strains may account for these observations.[10,11] These findings are thus consistent with the variable penetrance of the clinical presentation in individuals whose genome harbour-mutated KRT16 alleles,[2–4] and point to the Krt16 null mouse model as a useful resource to define the determinants involved.
3 | MATERIALS AND METHODS
The methods used in this study are described under “Data S1.”
Supplementary Material
FIGURE S1 Comparison of Krt16 null phenotypes between C57Bl/6 and FVB strain backgrounds
FIGURE S2 PPK Index: Assessment of Paw Lesion Severity
DATA S1 Supplemental Materials
TABLE S1 Total body weight (±standard deviation) at 2 months’ old
TABLE S2 Survival curve of FVB;Krt16−/− crossed with HPVtg/+ mice
Acknowledgments
The authors are grateful to Dr. Michelle Kerns, Joseph Shen and Tara Biser for advice and support. This work was supported by grant AR044232 from the National Institute of Arthritis, Musculoskeletal and Skin Diseases. AZ performed all experiments. AZ and PAC designed the experiments, interpreted the data and wrote the manuscript.
Footnotes
CONFLICT OF INTEREST
The authors have declared no conflicting interests.
ORCID
Pierre A. Coulombe, http://orcid.org/0000-0003-0680-2373
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article.
References
- 1.McGowan K, Coulombe PA. Subcell Biochem. 1998;31:173. [PubMed] [Google Scholar]
- 2.McLean WHI, Rugg EL, Lunny DP, Morley SM, Lane EB, Swensson O, Dopping-Hepenstal PJC, Griffiths WAD, Eady RAJ, Higgins C, Navsaria HA. Nat Genet. 1995;9:273. doi: 10.1038/ng0395-273. [DOI] [PubMed] [Google Scholar]
- 3.Leachman SA, Kaspar RL, Fleckman P, Florell SR, Smith FJ, McLean WI, Lunny DP, Milstone LM, Van Steensel MA, Munro CS, O’toole EA. J Investig Dermatol Symp Proc. 2005;10:3. doi: 10.1111/j.1087-0024.2005.10202.x. [DOI] [PubMed] [Google Scholar]
- 4.Shamsher MK, Navsaria HA, Stevens HP, Ratnavel RC, Purkis PE, Keisell DP, McLean WHI, Cook LJ, Griffiths WAD, Gschmeissner S, Spurr N. Hum Mol Genet. 1995;4:1875. doi: 10.1093/hmg/4.10.1875. [DOI] [PubMed] [Google Scholar]
- 5.Lessard JC, Coulombe PA. J Invest Dermatol. 2012;132:1384. doi: 10.1038/jid.2012.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lessard JC, Pina-Paz S, Rotty JD, Hickerson RP, Kaspar RL, Balmain A, Coulombe PA. Proc Natl Acad Sci USA. 2013;110:19537. doi: 10.1073/pnas.1309576110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kerns ML, Hakim JM, Lu RG, Guo Y, Berroth A, Kaspar RL, Coulombe PA. J Clin Invest. 2016;126:2356. doi: 10.1172/JCI84870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hobbs RP, DePianto DJ, Jacob JT, Han MC, Chung BM, Batazzi AS, Poll BG, Guo Y, Han J, Ong S, Zheng W, Taube JM, Cihakova D, Wan F, Coulombe PA. Nat Genet. 2015;47:933. doi: 10.1038/ng.3355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kerns ML, Hakim JM, Zieman A, Lu RG, Coulombe PA. J Invest Dermatol. 2017 Dec 22; doi: 10.1016/j.jid.2017.09.054. pii: S0022-202X1733234-7. [Epub ahead of print] in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sellers RS, Clifford CB, Treuting PM, Brayton C. Vet Pathol. 2012;49:32. doi: 10.1177/0300985811429314. [DOI] [PubMed] [Google Scholar]
- 11.Chaiuduri A, Wilson NS, Yang B, Paler Martinez A, Liu J, Zhu C, Bricker N, Couto S, Modrusan Z, French D, Cupp J, Ashkenazi A. Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associate macrophages. Immunology and Cell Biology. 2013;91:451. doi: 10.1038/icb.2013.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
FIGURE S1 Comparison of Krt16 null phenotypes between C57Bl/6 and FVB strain backgrounds
FIGURE S2 PPK Index: Assessment of Paw Lesion Severity
DATA S1 Supplemental Materials
TABLE S1 Total body weight (±standard deviation) at 2 months’ old
TABLE S2 Survival curve of FVB;Krt16−/− crossed with HPVtg/+ mice
